Małgorzata Kowal

Serum Levels of Selected Th17 and Th22 Cytokines in Psoriatic Patients

Anna Michalak-Stoma, Joanna Bartosińska, Małgorzata Kowal et al. · Disease Markers · 2013 · 104 citations · Full text

A multicenter, open, non‐comparative, phase II study of the combination of cladribine (2‐chlorodeoxyadenosine), cytarabine, and G‐CSF as induction therapy in refractory acute myeloid leukemia – a report of the Polish Adult Leukemia Group (PALG)

Agata Wrzesień‐Kuś, Tadeusz Robak, Ewa Lech‐Marańda et al. · European Journal Of Haematology · 2003 · 61 citations

Peptide vaccination elicits leukemia-associated antigen-specific cytotoxic CD8+ T-cell responses in patients with chronic lymphocytic leukemia

Krzysztof Giannopoulos, Anna Dmoszyńska, Małgorzata Kowal et al. · Leukemia · 2010 · 49 citations

Vaccination, Peptide Vaccination, Allergy +11

Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemia

Krzysztof Giannopoulos, Anna Dmoszyńska, Małgorzata Kowal et al. · Leukemia · 2009 · 47 citations

Hematological Malignancy, Oncology, Medicine +8

The VEGF receptor, neuropilin-1, represents a promising novel target for chronic lymphocytic leukemia patients

Agnieszka Piechnik, Anna Dmoszyńska, Marcin Omiotek et al. · International Journal of Cancer · 2013 · 44 citations · Full text

Lymphoid Neoplasia, Cancer Immunosurveillance, Receptor Tyrosine Kinase +15